Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial
- DIAMOND study group
研究成果: Article › 査読
76
リンクは新しいタブで開きます
被引用数
(Scopus)